QUÉBEC CITY, May 25,
2011 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS)
(TSX: AEZ) (the "Company") today announced that its Senior
Vice President and CFO, Dennis Turpin, CA, will make a corporate
presentation at the upcoming BioFinance 2011 Conference on
Wednesday, June 1, 2011, at
10:00 a.m. (Eastern time) in Room 1
of the St. Andrew's Club & Conference Centre in Toronto, Canada.
About Aeterna Zentaris Inc.
Aeterna Zentaris is a late-stage oncology drug
development company currently investigating potential treatments
for various cancers including colorectal, multiple myeloma,
endometrial, ovarian, prostate and bladder cancer. The Company's
innovative approach of "personalized medicine" means tailoring
treatments to a patient's specific condition and to unmet medical
needs. Aeterna Zentaris' deep pipeline is drawn from its
proprietary discovery unit providing the Company with constant and
long-term access to state-of-the-art therapeutic options. For more
information please visit www.aezsinc.com.
SOURCE AETERNA ZENTARIS INC.